according to the arrangement, the company’s shares will enter the delisting period on March 20, 2026, during which 15 trading days will be carried out. the final trading day will be April 10, 2026 and will be officially delisted on April 13, 2026.
The delisting of Long Pharmaceutical Holdings was mainly due to the false disclosure of information in its 2021-2023 annual report, which triggered the delisting risk clause related to financial fraud. It is worth mentioning that the company’s shares have entered the delisting period since March 20, 2026.
in June 2016, kang yue technology, the predecessor of long medicine withdrawal, successfully acquired 100 percent of the shares of photovoltaic equipment enterprise yi heng technology by combining the strategy of issuing shares and paying cash. By 2017, with the smooth completion of relevant transfer procedures, yi heng technology will officially become a wholly-owned subsidiary of kangyue technology. However, by the end of 2025, in view of the fierce competition environment in the photovoltaic industry, as well as Yi Heng Technology’s own capital constraints, continued losses, in order to prevent further expansion of losses and reduce operating costs, Yi Heng Technology decided to stop production.
